Here’s a **clear summary of the medical case report on insulin oedema (edema) in type 2 diabetes mellitus — a rare but real complication after starting or increasing insulin therapy:(PMC)
📘 Insulin Oedema in Type 2 Diabetes Mellitus — Case Report Summary
🧪 What Is Insulin Oedema?
Insulin oedema is a rare fluid‑retention condition that may occur after initiating or rapidly intensifying insulin therapy in people with poorly controlled diabetes. It leads to swelling in the extremities (hands/feet) and weight gain due to fluid accumulation.(PMC)
🧑⚕️ The Case
- The patient was a 57‑year‑old woman with long‑standing type 2 diabetes and poor blood sugar control. Her HbA1c was very high (around 10.7%) before insulin.(PMC)
- She was started on insulin therapy, including a basal insulin (glargine) and short‑acting insulin (aspart).(PMC)
- About 1 week after intensification of insulin, she developed bilateral swelling in her feet and hands and gained ~3 kg.(PMC)
📊 Medical Assessment
Doctors ruled out other common reasons for swelling (like heart, liver, or kidney failure). Lab tests and imaging did not show underlying organ dysfunction, which supported the diagnosis of insulin‑related oedema.(PMC)
🩺 Treatment & Outcome
- A short trial of furosemide (a diuretic) was given, but swelling didn’t immediately improve.(PMC)
- Over 3 months, the swelling resolved spontaneously on its own without long‑term harm.(PMC)
- Meanwhile, her blood sugars improved significantly (HbA1c dropped to ~6.9%).(PMC)
🧠 Why It Happens
Although the exact mechanism isn’t fully understood, several explanations have been suggested:
- Rapid correction of high blood sugar (glycemic control) may change osmotic balance, causing fluid to shift into tissues.(PMC)
- Increased sodium and water retention due to insulin’s effect on kidney sodium handling.(PMC)
- Changes in capillary permeability and fluid distribution during metabolic shifts.(PMC)
📍 Important Points for Patients
- This is rare and usually benign — it often resolves on its own with time and ongoing diabetes control.(PMC)
- It’s a diagnosis of exclusion: other causes of swelling must be ruled out first.(PMC)
- Awareness helps clinicians avoid misdiagnosis and unnecessary treatment alteration.(PMC)
📘 Bottom Line
Insulin oedema is an uncommon reaction seen shortly after starting or intensifying insulin therapy, characterized by swelling and weight gain. In many cases, it resolves over weeks to months as blood sugar stabilizes. Clinicians should recognize it to reassure patients and continue appropriate diabetes management.(PMC)
If you want, I can also explain how clinicians differentiate insulin oedema from other causes of swelling (e.g., heart failure, kidney problems) and what symptoms should prompt immediate medical attention. Would you like that?
